Tagged With Celgene

Rep. Katie Porter ripped into pharma executive Mark Alles for repeated price hikes on the cancer drug Revlimid


Amgen will buy a blockbuster psoriasis drug for $13.4 billion — and it's part of a plan to get Celgene's mega-merger with Bristol-Myers Squibb approved


Bristol-Myers Squibb is selling off a blockbuster drug to help its $74 billion merger with Celgene get approved — and now both stocks are tumbling



Dispensed: Pharma CEOs on Capitol Hill, the exploding CBD market, and treating kids with new models of primary care


Opposition to Bristol-Myers Squibb's $74 billion acquisition of Celgene could endanger the deal, and the whole situation is 'somewhat unprecedented'


Bristol-Myers' record-breaking $74 billion biotech deal is in jeopardy



The biggest healthcare investor conference starts on Monday — here are the top 5 areas we're keeping an eye on


Dispensed: A $74 billion mega-merger starts 2019 off with a bang and how a health system plans to disrupt itself before it's disrupted


Bristol-Myers Squibb is buying Celgene in a $74 billion deal


A startup that wants to use stem cells to keep us living longer just raised $250 million


The hottest thing in cancer drug development just won a $9 billion endorsement


Celgene is buying the cancer-drug maker Juno Therapeutics for $9 billion



The hottest thing in cancer drug development is a takeover target again -- here's what you need to know about it


Juno Therapeutics jumps 53% after report Celgene is interested in buying the cancer drugmaker


Celgene is reportedly in talks to buy a $5.5 billion cancer drugmaker


Traders were blindsided by Celgene's massive earnings flop



A startup trying to get the human body to fight cancer just filed for an IPO


A startup that wants to take cancer therapy to the next level just landed a $2.5 billion deal